Skip to main content

MoneyWorks4Me

Windlas Biotech informs about disclosure

04 May 2023 Evaluate
Windlas Biotech has informed regarding intimation of completion of Buyback by Windlas Biotech in terms of the provisions of Securities & Exchange Board of India (Buy Back of Securities) Regulations, 2018 (Buyback Regulations) through Open Market Route.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1876.70
Dr. Reddys Labs. 1381.30
Cipla 1403.70
Lupin 2016.95
Zydus Lifesciences 1195.35
View more..